• Japanese
  • Korean
  • Chinese
Home > Pharmaceutical > Molecular Targeted Therapeutics Market Research Reports

Molecular Targeted Therapeutics Market Research Reports

We offer market research, industry forecasts, and business analysis in the Molecular Targeted Therapeutics as well as other vertical industries. GII sells reports, databases, newsletters and annual information services that provide the latest market data, such as industry forecasts, projections, trends, market shares, research and development, sales and marketing strategies, and competitive analysis.

Filter
Title Search
1 - 25 of 202 Products
Sort by
Display
*
Published by
BioSeeker Group AB
Price
USD 2995
Content info
 
Sample available
*
Published by
BioSeeker Group AB
Price
USD 2250
Content info
 
Sample available
*
Published by
BioSeeker Group AB
Price
USD 2250
Content info
 
Sample available
*
Published by
BioSeeker Group AB
Price
USD 2250
Content info
 
Sample available
*
Published by
BioSeeker Group AB
Price
USD 2250
Content info
 
Sample available
*
Published by
BioSeeker Group AB
Price
USD 2250
Content info
 
Sample available
*
Published by
BioSeeker Group AB
Price
USD 2250
Content info
 
Sample available
*
Published by
BioSeeker Group AB
Price
USD 2250
Content info
 
Sample available
*
Published by
BioSeeker Group AB
Price
USD 2250
Content info
 
Sample available
There are today 67 companies plus partners developing 63 Wnt pathway targeting drugs in 192 developmental projects in cancer....
*
Published by
BioSeeker Group AB
Price
USD 2250
Content info
 
Sample available
There are today 139 companies plus partners developing 152 TNF-alpha pathway targeting drugs in 478 developmental projects in cancer....
*
Published by
BioSeeker Group AB
Price
USD 2250
Content info
 
Sample available
There are today 163 companies plus partners developing 168 TGF-beta receptor pathway targeting drugs in 394 developmental projects in cancer....
*
Published by
BioSeeker Group AB
Price
USD 2250
Content info
 
Sample available
There are today 152 companies plus partners developing 170 T cell receptor pathway targeting drugs in 507 developmental projects in cancer....
*
Published by
BioSeeker Group AB
Price
USD 2250
Content info
 
Sample available
Protein kinase inhibitors such as Gleevec, Iressa and Tarceva have allowed the biotechnology industry to deliver on the promise of targeted cancer drugs....
*
Published by
BioSeeker Group AB
Price
USD 2250
Content info
 
Sample available
There are today 70 companies plus partners developing 67 Notch pathway targeting drugs in 244 developmental projects in cancer....
*
Published by
BioSeeker Group AB
Price
USD 2250
Content info
 
Sample available
The Kit receptor signaling pathway includes activation of PI 3-kinase, Src family kinases and PLC gamma....
*
Published by
BioSeeker Group AB
Price
USD 1495
Content info
 
Sample available
The IL-9 signaling pathway activates Jak/STAT and MAPK signaling modules....
*
Published by
BioSeeker Group AB
Price
USD 750
Content info
 
Sample available
IL-7 signaling pathway mainly activates the JAK/STAT signaling module....
*
Published by
BioSeeker Group AB
Price
USD 2250
Content info
 
Sample available
The IL-6 signaling pathway activates the Jak/STAT, Ras/Raf/MAPK and PI 3-kinase signaling modules....
*
Published by
BioSeeker Group AB
Price
USD 2250
Content info
 
Sample available
There are today 108 companies plus partners developing 114 IL-5 pathway targeting drugs in 373 developmental projects in cancer....
*
Published by
BioSeeker Group AB
Price
USD 2250
Content info
 
Sample available
The IL-4 signaling pathway stimulates the JAK/STAT and MAPK signaling modules....
*
Published by
BioSeeker Group AB
Price
USD 2250
Content info
 
Sample available
The IL-3 signaling pathway activates the JAK/STAT, MAPK and PI 3-kinase signaling modules....
*
Published by
BioSeeker Group AB
Price
USD 2250
Content info
 
Sample available
There are today 185 companies plus partners developing 258 IL-2 pathway targeting drugs in 746 developmental projects in cancer....
*
Published by
BioSeeker Group AB
Price
USD 1495
Content info
 
Sample available
There are today 53 companies plus partners developing 42 IL-1 pathway targeting drugs in 162 developmental projects in cancer....
*
Published by
BioSeeker Group AB
Price
USD 2250
Content info
 
Sample available
There are today 20 companies plus partners developing 20 Hedgehog pathway targeting drugs in 83 developmental projects in cancer....
*
Published by
BioSeeker Group AB
Price
USD 2250
Content info
 
Sample available
The EGFR1 signaling pathway activates the Ras/Raf/MAPK signaling modules....
Back to Top